Transforming Growth Factor Beta 2 (TGFB2) mRNA Levels, in Conjunction with Interferon-Gamma Receptor Activation of Interferon Regulatory Factor 5 (IRF5) and Expression of CD276/B7-H3, Are Therapeutically Targetable Negative Prognostic Markers in Low-Grade Gliomas.

Autor: Trieu V; Oncotelic Therapeutics, 29397 Agoura Road, Suite 107, Agoura Hills, CA 91301, USA., Maida AE; Oncotelic Therapeutics, 29397 Agoura Road, Suite 107, Agoura Hills, CA 91301, USA., Qazi S; Oncotelic Therapeutics, 29397 Agoura Road, Suite 107, Agoura Hills, CA 91301, USA.

Publikováno v: Cancers [Cancers (Basel)] 2024 Mar 19; Vol. 16 (6). Date of Electronic Publication: 2024 Mar 19.

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Autor: Liau LM; University of California Los Angeles (UCLA) David Geffen School of Medicine & Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. lliau@mednet.ucla.edu., Ashkan K; King's College London School of Medical Education, London, UK., Tran DD; University of Florida, Gainesville, FL, USA., Campian JL; Washington University, St. Louis, MO, USA., Trusheim JE; Abbott Northwestern Hospital, Minneapolis, MN, USA., Cobbs CS; Swedish Medical Center, Swedish Neuroscience Institute, Seattle, WA, USA., Heth JA; University of Michigan Medical School, Ann Arbor, MI, USA., Salacz M; University of Kansas Cancer Center, Kansas City, KS, USA., Taylor S; University of Kansas Cancer Center, Kansas City, KS, USA., D'Andre SD; Sutter Institute for Medical Research, Sacramento, CA, USA., Iwamoto FM; Columbia University Medical Center, New York, NY, USA., Dropcho EJ; Indiana University Simon Cancer Center, Indianapolis, IN, USA., Moshel YA; Overlook Medical Center, Summit, NJ, USA., Walter KA; University of Rochester Medical Center, Rochester, NY, USA., Pillainayagam CP; Rush University Medical Center, Rochester, USA., Aiken R; Rutgers Cancer Institute, New Brunswick, NJ, USA., Chaudhary R; University of Cincinnati Medical Center, Cincinnati, OH, USA., Goldlust SA; Hackensack University Medical Center, Hackensack, NJ, USA., Bota DA; UC Irvine Medical Center, Irvine, CA, USA., Duic P; Winthrop-University Hospital, Mineola, NY, USA., Grewal J; NYU Winthrop Hospital, Mineola, NY, USA., Elinzano H; Rhode Island Hospital, Providence, RI, USA., Toms SA; Rhode Island Hospital, Providence, RI, USA., Lillehei KO; University of Colorado Hospital, Aurora, CO, USA., Mikkelsen T; Henry Ford Health System, Detroit, MI, USA., Walbert T; Henry Ford Health System, Detroit, MI, USA., Abram SR; St. Thomas Research Institute, Nashville, TN, USA., Brenner AJ; University of Texas Health Science Center, San Antonio, TX, USA., Brem S; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Ewend MG; University of North Carolina, Chapel Hill, NC, USA., Khagi S; University of North Carolina, Chapel Hill, NC, USA., Portnow J; City of Hope National Medical Center, Duarte, CA, USA., Kim LJ; Thomas Jefferson University, Philadelphia, PA, USA., Loudon WG; St. Joseph Hospital, Newport Beach, CA, USA., Thompson RC; Vanderbilt University, Nashville, TN, USA., Avigan DE; Beth Israel Deaconess Medical Center, Boston, MA, USA., Fink KL; Baylor University Medical Center, Dallas, TX, USA., Geoffroy FJ; Illinois CancerCare, Peoria, IL, USA., Lindhorst S; Medical University of South Carolina, Charleston, SC, USA., Lutzky J; Mount Sinai Comprehensive Cancer Center, Miami, FL, USA., Sloan AE; University Hospitals Case Medical Center, Cleveland, OH, USA., Schackert G; University Hospital Carl-Gustav-Carus of Technical University, Dresden, Germany., Krex D; University Hospital Carl-Gustav-Carus of Technical University, Dresden, Germany., Meisel HJ; BG-Klinikum Bergmannstrost, Halle, Germany., Wu J; Tufts University School of Medicine, Boston, MA, USA., Davis RP; Stony Brook University, Stony Brook, NY, USA., Duma C; Hoag Cancer Center, Newport Beach, CA, USA., Etame AB; H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, USA., Mathieu D; CHUS-Hopital Fleurimont, Sherbrooke University, Sherbrooke, QC, Canada., Kesari S; UCSD Health System, UC San Diego, San Diego, CA, USA., Piccioni D; UCSD Health System, UC San Diego, San Diego, CA, USA., Westphal M; Neurochirurgische Klinik University Clinic Hamburg-Eppendorf, Hamburg, Germany., Baskin DS; Houston Methodist, Houston, TX, USA., New PZ; Houston Methodist, Houston, TX, USA., Lacroix M; Geisinger Health System, Danville, PA, USA., May SA; Klinikum Chemnitz GGMBH, Chemnitz, Germany., Pluard TJ; Saint Luke's Cancer Institute, Kansas City, MO, USA., Tse V; Kaiser Permanente Northern California, Redwood City, CA, USA., Green RM; Kaiser Permanente Southern California, Los Angeles, CA, USA., Villano JL; University of Kentucky College of Medicine, Lexington, KY, USA., Pearlman M; Colorado Neurological Institute, Englewood, CO, USA., Petrecca K; Montreal Neurological Institute and Hospital, McGill University, Montreal, Canada., Schulder M; Northwell Hofstra School of Medicine, Lake Success, NY, USA., Taylor LP; Department of Neurology, Alvord Brain Tumor Center, University of Washington, Seattle, WA, USA., Maida AE; Northwest Biotherapeutics Inc., Bethesda, MD, USA., Prins RM; University of California Los Angeles (UCLA) David Geffen School of Medicine & Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA., Cloughesy TF; University of California Los Angeles (UCLA) David Geffen School of Medicine & Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA., Mulholland P; University College Hospitals, London, UK., Bosch ML; Northwest Biotherapeutics Inc., Bethesda, MD, USA. marnix@nwbio.com.

Publikováno v: Journal of translational medicine [J Transl Med] 2018 May 29; Vol. 16 (1), pp. 142. Date of Electronic Publication: 2018 May 29.